
Preclinical Studies
After a lead compound has been identified and optimized, researchers can pursue a broad range of follow-up experiments to assess the drug’s activity in cells or model organisms. By comprehensively characterizing a drug and its effects, these efforts pave the way for the transition to clinical trials, in which the drug is ultimately tested on human volunteers or patients. Preclinical studies provide valuable information to ensure the safety, efficacy and deliverability of a potential therapeutic, assessing both on- and off-target activity in complex biological systems. To be most productive, this research requires thoughtful assay development, a high level of quantitative accuracy, and sophisticated bioinformatics analyses to synthesize diverse experimental data. By integrating these features into our services, we can accelerate the preclinical research process for our clients.

